Pol theta enzyme identified as key driver of cancer resilience
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized.
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized.